全文获取类型
收费全文 | 1009篇 |
免费 | 80篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 50篇 |
妇产科学 | 6篇 |
基础医学 | 138篇 |
口腔科学 | 10篇 |
临床医学 | 123篇 |
内科学 | 206篇 |
皮肤病学 | 10篇 |
神经病学 | 66篇 |
特种医学 | 99篇 |
外科学 | 71篇 |
综合类 | 13篇 |
预防医学 | 80篇 |
眼科学 | 8篇 |
药学 | 80篇 |
中国医学 | 2篇 |
肿瘤学 | 127篇 |
出版年
2021年 | 6篇 |
2020年 | 10篇 |
2019年 | 13篇 |
2018年 | 15篇 |
2017年 | 9篇 |
2016年 | 14篇 |
2015年 | 11篇 |
2014年 | 17篇 |
2013年 | 32篇 |
2012年 | 31篇 |
2011年 | 31篇 |
2010年 | 33篇 |
2009年 | 31篇 |
2008年 | 45篇 |
2007年 | 37篇 |
2006年 | 40篇 |
2005年 | 31篇 |
2004年 | 22篇 |
2003年 | 20篇 |
2002年 | 28篇 |
2001年 | 25篇 |
2000年 | 17篇 |
1999年 | 37篇 |
1998年 | 30篇 |
1997年 | 36篇 |
1996年 | 36篇 |
1995年 | 34篇 |
1994年 | 33篇 |
1993年 | 28篇 |
1992年 | 29篇 |
1991年 | 25篇 |
1990年 | 29篇 |
1989年 | 32篇 |
1988年 | 19篇 |
1987年 | 24篇 |
1986年 | 24篇 |
1985年 | 18篇 |
1984年 | 9篇 |
1983年 | 9篇 |
1982年 | 7篇 |
1981年 | 16篇 |
1980年 | 13篇 |
1979年 | 6篇 |
1977年 | 10篇 |
1976年 | 14篇 |
1975年 | 8篇 |
1974年 | 8篇 |
1973年 | 6篇 |
1970年 | 4篇 |
1966年 | 4篇 |
排序方式: 共有1095条查询结果,搜索用时 125 毫秒
1.
2.
3.
Performance characteristics of pooled rabbit IgG polyclonal anti-C3d are compared with one mouse IgM and three mouse IgG monoclonal anti-C3d antibodies (MAs). IgG MA,s employed singly or in combination, failed to precipitate C3d; by contrast, IgM MA and polyclonal anti-C3d precipitated C3d. Measurements of polyclonal anti-C3d concentration by chemical means and by 125I-C3d radioimmunoassay (RIA) agreed closely. RIA values were 50% of chemical measurement values for three of the four MAs. Use of sucrose density gradient ultracentrifugation to assess MA C3d/anti-C3d molar combining ratios for soluble anti-C3d/C3d was not possible because fast-sedimenting multimeric C3d/anti-C3d complexes did not form. Dissociation and competitive binding studies indicate that (1) two MAs had substantially lower affinities than the other anti-C3d antibodies, and (2) polyclonal anti-C3d recognizes more C3d epitopes than are recognized by individual MAs. The results demonstrate antigenic complexity of C3d fragment and illustrate the difficulties of predicting individual MA performance based on prior experience with polyclonal antibodies. 相似文献
4.
The Barnes Hospital Apheresis Blood Collection and Blood Transfusion Unit is part of Barns Hospital Blood Bank. Because of its size and complexity, we report our experience which may be useful to administrators and physicians involved in the planning or management of similar services. From 1985 through 1988 we collected platelets from 1,976 different donors, the majority of which (87%) were community donors. Sixty-nine percent of 1,976 donors donated in 1988 an average of 4.9 times. Of 6,568 apheresis products collected. 1.1% were discarded because of positive screening tests and 0.7% were discarded because of outdating or presence of fibrin clot. In 1988 a total of nine cell separators were used. All donor apheresis were done with seven blood separators, and on average a separator produced an apheresis product every 4.5 worked hours. All therapeutic apheresis (338) were done on two separators. Most of them (88%) were performed during work hours. In 1988 donor and therapeutic apheresis were done by 17 1/2 full-time employees (FTEs) during work hours. Considering the Workload Unit Value per procedure given by the College of American Pathologists (CAP) and that each FTE worked 1,864 hours per year, the worked hour productivity for donor and therapeutic apheresis was 78.2%. Blood collections, therapeutic bleeds, and outpatient transfusions (1,127, 114 and 1,745 respectively) were accomplished by two FTEs, for a worked hour productivity of 35.5%. Because 95.1% of total worked units was produced by efficient donor and therapeutic apheresis activities, overall efficiency remained high at 73.8%. 相似文献
5.
6.
7.
8.
Nina Rieckmann William Gerin Ian M Kronish Matthew M Burg William F Chaplin Grace Kong Fran?ois Lespérance Karina W Davidson 《Journal of the American College of Cardiology》2006,48(11):2218-2222
OBJECTIVES: We tested whether improvements in depressive symptoms precede improved adherence to aspirin in patients with acute coronary syndromes (ACS). BACKGROUND: Depression is associated with medication nonadherence in patients with ACS, but it is unclear whether changes in depression impact on adherence. METHODS: Electronic medication monitoring was used to measure adherence to aspirin during a 3-month period in a consecutive cohort of 172 patients (25 to 85 years) recruited within 1 week of hospitalization for ACS. Depressive symptom severity was assessed using the Beck Depression Inventory (BDI) during hospitalization and at 1 and 3 months after hospitalization. Adherence was defined as the percentage of days aspirin was taken as prescribed. RESULTS: Depression severity in hospital was associated with nonadherence in a gradient fashion: 15% of non-depressed patients (BDI score 0 to 4), 29% of mildly depressed patients (BDI score 10 to 16), and 37% of patients with moderately-to-severely depressive symptoms (BDI score >16) took aspirin less than 80% of the time (p = 0.03). A cross-lagged path analytic model revealed that improvements in depressive symptoms in the first month after the ACS were associated with improvements in adherence rates in the subsequent 2 months (standardized direct effect -0.32, p = 0.016). CONCLUSIONS: Diagnosis and treatment of depressive symptoms may improve medication adherence in patients after ACS. 相似文献
9.
10.
L. D. Skarsgard M. W. Skwarchuk A. Vinczan D. J. Chaplin 《British journal of cancer》1993,68(4):681-683
We have observed that low pH can substantially potentiate the cytotoxic effect of the bioreductive drug SR4233 in aerobic HT-29 human tumour cells. No such potentiation was observed under hypoxic conditions. This pH effect might be relevant both to the therapeutic effectiveness and to the normal tissue toxicity of this new agent. 相似文献